Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRODIE B. B. Physiological disposition and chemical fate of thiobarbiturates in the body. Fed Proc. 1952 Jun;11(2):632–639. [PubMed] [Google Scholar]
- Brodie B. B. Physicochemical and biochemical aspects of pharmacology. JAMA. 1967 Nov 13;202(7):600–609. [PubMed] [Google Scholar]
- Buckley J. P., Steenberg M. L., Barry H., 3rd, Manian A. A. Pharmacology of mono- and disubstituted chlorpromazine metabolites. J Pharm Sci. 1973 May;62(5):715–722. doi: 10.1002/jps.2600620503. [DOI] [PubMed] [Google Scholar]
- Curry S. H. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med. 1971 Mar;64(3):285–289. doi: 10.1177/003591577106400323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Curry S. H. Drug distribution and effect. J R Coll Physicians Lond. 1970 Jul;4(4):315–334. [PMC free article] [PubMed] [Google Scholar]
- Curry S. H., Gordon J. S., Riddall D., Simpson P., Binns T. B., Rondel R. K., McMartin C. Disposition of glutethimide in man. Clin Pharmacol Ther. 1971 Sep-Oct;12(5):849–857. doi: 10.1002/cpt1971125849. [DOI] [PubMed] [Google Scholar]
- Curry S. H., Norris H. Acute tolerance to a sedative in man. Br J Pharmacol. 1970 Feb;38(2):450P–451P. [PMC free article] [PubMed] [Google Scholar]
- Fry D. E., Marks V. Value of plasma-lithium monitoring. Lancet. 1971 May 1;1(7705):886–888. doi: 10.1016/s0140-6736(71)92444-5. [DOI] [PubMed] [Google Scholar]
- Hammer W. M., Brodiet B. B. Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride. J Pharmacol Exp Ther. 1967 Sep;157(3):503–508. [PubMed] [Google Scholar]
- Jones B. M., Vega A. Cognitive performance measured on the ascending and descending limb of the blood alcohol curve. Psychopharmacologia. 1972;23(2):99–114. doi: 10.1007/BF00401185. [DOI] [PubMed] [Google Scholar]
- KRUEGER-THIEMER E. Dosage schedule and pharmacokinetics in chemotherapy. J Am Pharm Assoc Am Pharm Assoc. 1960 May;49:311–313. [PubMed] [Google Scholar]
- Leff J. P., Wing J. K. Trial of maintenance therapy in schizophrenia. Br Med J. 1971 Sep 11;3(5775):599–604. doi: 10.1136/bmj.3.5775.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malpas A., Rowan A. J., Boyce C. R., Scott D. F. Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium. Br Med J. 1970 Jun 27;2(5712):762–764. doi: 10.1136/bmj.2.5712.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller R. J., Iversen L. L. Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum. J Pharm Pharmacol. 1974 Feb;26(2):142–144. doi: 10.1111/j.2042-7158.1974.tb09243.x. [DOI] [PubMed] [Google Scholar]
- Nagashima R., O'Reilly R. A., Levy G. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther. 1969 Jan-Feb;10(1):22–35. doi: 10.1002/cpt196910122. [DOI] [PubMed] [Google Scholar]
- Oswald I., Priest R. G. Five Weeks to Escape the Sleeping-pill Habit. Br Med J. 1965 Nov 6;2(5470):1093–1095. doi: 10.1136/bmj.2.5470.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robin A., Curry S. H., Whelpton R. Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med. 1974 Nov;4(4):388–392. doi: 10.1017/s0033291700045839. [DOI] [PubMed] [Google Scholar]
- Sakalis G., Curry S. H., Mould G. P., Lader M. H. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):931–946. doi: 10.1002/cpt1972136931. [DOI] [PubMed] [Google Scholar]
